Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:1793-1800

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, J. D.
Right arrow Articles by Colucci, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, J. D.
Right arrow Articles by Colucci, W. S.

(Circulation. 1995;92:1793-1800.)
© 1995 American Heart Association, Inc.


Articles

Functional Significance of Presynaptic {alpha}-Adrenergic Receptors in Failing and Nonfailing Human Left Ventricle

John D. Parker, MD; Gary E. Newton, MD; Joel S. Landzberg, MD; John S. Floras, MD, DPhi; Wilson S. Colucci, MD

From the Cardiovascular Division (J.D.P., G.E.N., J.S.F.), Departments of Medicine, Mount Sinai Hospital and the Toronto Hospital, University of Toronto, Toronto, Ontario, Canada; and the Cardiovascular Division (J.S.L., W.S.C.), Departments of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.

Correspondence to John D. Parker, MD, Cardiovascular Division, Rm 1609, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5.

Background There are {alpha}-adrenergic receptors on human myocardium that exert positive inotropic effects. The effect of {alpha}-adrenergic receptor blockade on human left ventricular (LV) performance has not been fully explored. Although {alpha}-adrenergic receptor blockade might have effects on LV function that are mediated via blockade of postsynaptic myocardial {alpha}-adrenergic receptors, it is also possible that blockade of presynaptic {alpha}2-adrenergic receptors and subsequent increased release of norepinephrine would have effects on LV performance. In the present study, we explored the effects of nonselective {alpha}-adrenergic receptor blockade on LV performance and transcardiac norepinephrine concentrations in a group of patients with normal LV function and in a group of patients with congestive heart failure secondary to dilated cardiomyopathy.

Methods and Results Using an intracoronary drug infusion technique, we administered the nonselective {alpha}-adrenergic antagonist phentolamine to 13 patients with normal LV function and 19 patients with congestive heart failure secondary to dilated cardiomyopathy. With a high-fidelity LV catheter, the systolic (+dP/dt) and diastolic (-dP/dt and Tau) LV function responses to intracoronary infusion of phentolamine (0.2 mg/minx5 minutes) were assessed. In 8 patients with normal ventricular function and 10 patients with congestive heart failure, arterial and coronary sinus blood samples were drawn to determine the effects of phentolamine on catecholamine concentrations. Phentolamine had no measurable effect on LV performance or catecholamine concentrations in the normal ventricular function group. In patients with congestive heart failure, intracoronary phentolamine caused a significant increase in +dP/dt and the rate of isovolumic LV relaxation (-dP/dt and Tau). These hemodynamic effects were accompanied by a significant increase in coronary sinus norepinephrine concentration but no change in arterial norepinephrine concentration.

Conclusions Myocardial {alpha}-adrenergic receptor blockade causes significant inotropic and lusitropic effects in the failing but not the nonfailing human LV. These effects appear to be mediated by increased release of norepinephrine from cardiac nerves secondary to blockade of presynaptic {alpha}2-adrenergic receptors. Differences in the responses of the failing and nonfailing human LV appear to reflect the higher level of sympathetic activation that is seen in the group with congestive heart failure. This suggests that the presynaptic {alpha}2-adrenergic receptor exerts a tonic inhibitory effect on the release of norepinephrine from cardiac nerves in patients with congestive heart failure.


Key Words: receptors • adrenergic • alpha • diastole • cardiomyopathy




This article has been cited by other articles:


Home page
In VivoHome page
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
In Vivo, September 1, 2009; 23(5): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. S. Floras
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. S. Akers and L. A. Cassis
Presynaptic modulation of evoked NE release contributes to sympathetic activation after pressure overload
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2151 - H2158.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. M. Small, L. E. Wagoner, A. M. Levin, S. L.R. Kardia, and S. B. Liggett
Synergistic Polymorphisms of {beta}1- and {alpha}2C-Adrenergic Receptors and the Risk of Congestive Heart Failure
N. Engl. J. Med., October 10, 2002; 347(15): 1135 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras
Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure
Eur. Heart J., May 2, 2002; 23(10): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Aggarwal, M. D. Esler, F. Socratous, and D. M. Kaye
Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. F. Notarius and J. S. Floras
Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure
Europace, January 1, 2001; 3(1): 29 - 38.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. E. Newton, E. R. Azevedo, and J. D. Parker
Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study
Circulation, May 11, 1999; 99(18): 2402 - 2407.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. R. Azevedo, G. E. Newton, and J. D. Parker
Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. C. Lang, C. M. Stein, R. A. Nelson, H. B. He, F. J. Belas, I. A. Blair, M. Wood, and A. J. J. Wood
Sympathoinhibitory Response to Clonidine Is Blunted in Patients With Heart Failure
Hypertension, September 1, 1997; 30(3): 392 - 397.
[Abstract] [Full Text]


Home page
CirculationHome page
G. E. Newton and J. D. Parker
Acute Effects of ß1-Selective and Nonselective ß-Adrenergic Receptor Blockade on Cardiac Sympathetic Activity in Congestive Heart Failure
Circulation, August 1, 1996; 94(3): 353 - 358.
[Abstract] [Full Text]


Home page
CirculationHome page
G. L. Stiles
`A Riddle Wrapped in a Mystery Inside an Enigma' : Winston S. Churchill, October 1, 1939
Circulation, October 1, 1995; 92(7): 1678 - 1679.
[Full Text]